Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA pluripotin CTRPv2 pan-cancer AAC -0.022 0.6
mRNA ML050 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.6
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.045 0.6
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.023 0.6
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA C6-ceramide CTRPv2 pan-cancer AAC -0.022 0.6
mRNA BRD1835 CTRPv2 pan-cancer AAC 0.022 0.6
Download CSV